Power Management Mobile Devices IVD Devices

From clothes and accessory brands to auto manufacturers, electronics manufacturers and even medical device companies, the problem of counterfeit merchandise is growing. Devices at Risk: Fake pharmaceuticals are scary, but there's an equally alarming trend toward imitation medical devices.

Thermoplastic Elastomers in Medical Devices - White Paper Safety factors, barrier properties and applications of TPEs in medical devices This white paper details how TPEs can be used to meet global demand for healthcare devices and apparatus

work in designing and developing the USee™ self-refraction device for 2020, a nonprofit organization founded by the device inventor As an IDEA-winning design, the USee device will be part of the permanent collection at

The award recognizes PolyOne’s work in designing and developing the USee™ self-refraction device for Global Vision 2020, a nonprofit organization founded by the device inventor J. As an IDEA-winning design, the USee device will be part of the permanent collection at The Henry Ford Museum of American Innovation (Dearborn, Mich.), an IDSA partner. This award is proof that the USee device not only graduated, but was the valedictorian.

PolyOne Distribution: •    Expert team works with medical device customers to provide a combination of resources, technical understanding and material solutions to help discover the polymer formulations that are ideal for specific applications WithStand™ Antimicrobial Technology: •    Additive that helps hospitals in non-acute care settings where minor lapses in cleaning protocol can lead to medical device performance problems •    Proven performance in engineered medical grade polymers with efficacy against primary known antibiotic-resistant organisms   OnCap™ Lasermarking Additive: •    Enables permanent alphanumeric character, graphic or barcode information for identification that does not fade over time for Unique Device Identification (UDI) •    Provides consistent and efficient marking without altering, damaging or changing electrical or mechanical properties in sensitive medical devices   OnColor™ HC and HC Plus Colorants: •    Regulatory compliant and biocompatible solid colorants •    Enable confidence that brand color choice will perform as expected for regulatory requirements, performance, and conditions of use   Royalite™ Fire-Rated ABS Sheet: •    Helps meet stringent flame rating requirements while creating thermoformed housings and components  •    Aesthetically appealing and easily machined and finished Trilliant™ HC Thermoplastics: •    High-performance formulations with excellent chemical resistance and durability for medical device enclosures  •    Available in standard grades, or can be custom formulated from an array of base polymers to meet performance and aesthetic targets   NEU™ Specialty Thermoplastic Polyurethane:  •    Formulated to combine elasticity with abrasion and tear resistance for catheter tubing and tips •    Specification processing assists OEMs and processors in delivering solutions that match formulary requirements

Product Carbon Footprint (PCF) Calculator

To meet the FERC requirements, each utility company was required to perform a risk assessment of their systems, identify the most critical assets within the power grid, and then propose and implement a plan to protect them. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/tough-enough-to-protect-the-power-grid-southern-states-llc-selects-glasarmor-panels-from-polyone-300287353.html

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: the time required to consummate the proposed divestiture; the satisfaction or waiver of conditions in the sale agreement; any material adverse changes in the business supporting the PP&S assets being sold; the ability to obtain required regulatory or other third-party approvals and consents and otherwise consummate the proposed divestiture; our ability to identify and evaluate acquisition targets and consummate and integrate acquisitions; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to raise or sustain prices for products or services; an ability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to acquisitions and integration, working capital reductions, cost reductions and employee productivity goals; information systems failures and cyberattacks; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation. With respect to our outlook for full-year 2019 adjusted EPS from continuing operations, the company does not provide a reconciliation of this forward-looking non-GAAP financial measure to its most comparable GAAP financial measure because it is not possible for the company to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available due to the inherent difficulty of forecasting the timing and amounts of special items.

The Company does not provide reconciliations of forward-looking non-GAAP financial measures, such as outlook for adjusted earnings per share, to the most comparable GAAP financial measures on a forward-looking basis because the Company is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. Below is a reconciliation of these non-GAAP financial measures to their most directly comparable financial measures calculated and presented in accordance with GAAP. Below is a reconciliation of these non-GAAP financial measures to their most directly comparable financial measures calculated and presented in accordance with GAAP.